drugset / Trial / NCT00128544

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

NCT00128544

Phase 2 Completed 130 enrolled Novartis Novartis Pharmaceuticals · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to compare the effectiveness of the combination of valtorcitabine and telbivudine to telbivudine alone in patients with chronic hepatitis B.

Timeline

Start
2005-05
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Telbivudine Small molecule
Subject valtorcitabine Small molecule